Dental materials : official publication of the Academy of Dental Materials · 2026
Improvement of the biological performance of filling materials for primary teeth after pulpectomy by incorporating Ca-polyP microparticles.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ouyang Yun, Wang Jinwen, Ma Jiali, Yu Jian, Zhou Huan, Yang Lei, Yuan Guohua
Аннотация
OBJECTIVES: Calcium Hydroxide/Iodoform pastes (CH-I) are used for pulpectomy in primary teeth. To alleviate the rapid degradation of CH-I, polyphosphate (poly P) was incorporated with CH to form a modified paste (CH-PP-I), which was evaluated against CH-I and a commercial paste (Vitapex®).
METHODS: Vitapex, CH-I and CH-PP-I were compared for injectability, viscosity, pH, Ca2 + release and solubility. Antimicrobial properties of the pastes were tested using Enterococcus faecalis (E. faecalis). Their effects on human periodontal ligament cells (hPDLCs) were explored using CCK-8, Edu and TUNEL assays. Their impact on osteogenic and osteoclastic differentiation was detected on dental follicle stem cells (DFSCs) and bone marrow mononuclear cells (BMMs). The test materials were implanted subcutaneously to assess in vivo biocompatibility and degradation rates.
RESULTS: CH-PP-I released calcium more slowly and consistently than CH-I. CH-PP-I showed superior bacteriostatic properties than Vitapex, similar to CH-I. CH-PP-I exhibited lower cytotoxicity on hPDLCs compared to Vitapex and CH-I, with cell proliferation and apoptosis barely affected. CH-PP-I also promoted osteogenic differentiation of DFSCs and inhibited osteoclast differentiation of BMMs. Subcutaneous implantation revealed moderate inflammation in CH-PP-I and CH-I groups, while severe inflammation in the Vitapex group on day 15. After 60 days, all groups showed mild to moderate inflammation, and CH-PP-I had the lowest degradation rate on day 90.
SIGNIFICANCE: CH-PP-I exhibited more excellent antimicrobial activity and a lower degradation rate than CH-I and Vitapex, highlighting its potential as a promising filling paste for primary teeth.
METHODS: Vitapex, CH-I and CH-PP-I were compared for injectability, viscosity, pH, Ca2 + release and solubility. Antimicrobial properties of the pastes were tested using Enterococcus faecalis (E. faecalis). Their effects on human periodontal ligament cells (hPDLCs) were explored using CCK-8, Edu and TUNEL assays. Their impact on osteogenic and osteoclastic differentiation was detected on dental follicle stem cells (DFSCs) and bone marrow mononuclear cells (BMMs). The test materials were implanted subcutaneously to assess in vivo biocompatibility and degradation rates.
RESULTS: CH-PP-I released calcium more slowly and consistently than CH-I. CH-PP-I showed superior bacteriostatic properties than Vitapex, similar to CH-I. CH-PP-I exhibited lower cytotoxicity on hPDLCs compared to Vitapex and CH-I, with cell proliferation and apoptosis barely affected. CH-PP-I also promoted osteogenic differentiation of DFSCs and inhibited osteoclast differentiation of BMMs. Subcutaneous implantation revealed moderate inflammation in CH-PP-I and CH-I groups, while severe inflammation in the Vitapex group on day 15. After 60 days, all groups showed mild to moderate inflammation, and CH-PP-I had the lowest degradation rate on day 90.
SIGNIFICANCE: CH-PP-I exhibited more excellent antimicrobial activity and a lower degradation rate than CH-I and Vitapex, highlighting its potential as a promising filling paste for primary teeth.